€10M of bank debt negotiated and €1M+ in R&D grants for an industrial manufacturer
Catalan manufacturer of industrial capital goods for the pharmaceutical, chemical and petrochemical sectors, with a multi-entity holding structure. The engagement required restructuring the group's finance function, leading bank negotiations to fund critical commercial and technological initiatives, and capturing competitive public funding for R&D projects.
We took over corporate financial leadership with direct reporting to the Shareholders' Board. We negotiated €10M in bank debt, secured €1M+ in grants through 15 successful applications, and optimised working capital, freeing +€5M of cash to cover investments and operating needs. We led the SAGE 200 finance implementation and Factorial HR rollout, with a 20% reduction in audit costs.
€5M raised from venture capital and finance function built from scratch
E-commerce retail group with 5 online stores operating in more than 20 European countries and €30M in annual revenue. No structured finance function existed: inconsistent reporting, no KPIs, no cash management, strained treasury. The Board — made up of 13 entities across venture capital and private equity — demanded reliable monthly visibility.
We built the entire finance department from scratch: internal reporting standards, KPIs, budget control, cash management tooling and payment policy. We restructured financial debt and led a €5M capital raise in a round with VC and private funds. We selected and implemented NetSuite as the ERP for multi-country operations. We ran due diligence for several M&A processes.
Transfer pricing policy and KPMG audit coordinated across 5 countries
International trading group in the supply-chain sector with operations in the United Kingdom, Estonia, Malta, Spain and Russia. Strategic supplier to CHEP (Brambles). The multi-jurisdiction complexity and annual KPMG audit demanded a coherent financial framework, defensible before tax authorities in different countries.
We designed the group's financial policy framework from scratch: consolidated reporting, transfer pricing policy applicable in all 5 jurisdictions and cross-jurisdiction compliance. We coordinated the annual KPMG audit, opened the Maltese subsidiary in 2018, and rolled out SAGE X3 across all group units. Direct management of an internal team distributed across 3 countries + an external team.
€46M insurance programme and European refinancing for a pharmaceutical distributor
Russian subsidiary of a Spanish multinational pharmaceutical group, distributing and selling active pharmaceutical ingredients (APIs), with €100M in annual revenue and an internal team of 19. The entity required dual compliance (Spanish HQ + Russian regulation), refinancing of debt with European banks, and a forensic audit after inconsistencies were detected in contractual covenants.
We took on local financial control leadership, reporting to the group CFO and Managing Director. We structured a €46M insurance programme (€35M in receivables + €11M in fixed assets). We refinanced bank debt with European institutions. We carried out a forensic audit of all contracts and identified undocumented maturities and exposures. We led the SAP implementation.
